{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:27:43Z","timestamp":1790724463742,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Tick-borne encephalitis (TBE) is an infection by the tick-borne encephalitis virus (TBEV) with symptoms of central nervous system inflammation. TBE is endemic in Latvia and other parts of Europe. TBE vaccination is recommended for children in Latvia. TBE vaccine effectiveness (VE) was estimated in Latvia, a country with high TBE incidence, providing the first VE estimates against a range of TBEV infection outcomes in children 1\u201315 years-of-age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>R\u012bga Stradin\u0161 University conducted nationwide surveillance for suspected TBE cases. Serum and cerebrospinal fluid were ELISA tested for TBEV-specific IgG and IgM antibodies. A fully vaccinated child was an individual who had received the 3-dose primary series and appropriately timed boosters. The proportion of laboratory-confirmed TBE cases fully vaccinated (PCV) was determined from interviews and medical records. The proportion of the general population fully vaccinated (PPV) was determined from national surveys conducted in 2019 and 2020. TBE VE in children 1\u201315 years-of-age was estimated using the screening method: VE = 1 \u2212 [PCV\/(1 \u2212 PCV)\/PPV\/(1 \u2212 PPV)].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>From 2018 to 2020, surveillance identified 36 TBE cases in children 1\u201315 years-of-age; all were hospitalized, 5 (13.9%) for &gt;12 days. Of the TBE cases, 94.4% (34\/36) were unvaccinated compared with 43.8% of children in the general population. VE against TBE hospitalization in children 1\u201315 years-of-age was 94.9% (95% confidence interval 63.1\u201399.3). In 2018\u20132020, vaccination in children 1\u201315 years-of-age averted 39 hospitalized TBE cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Pediatric TBE vaccines were highly effective in preventing TBE in children. Increasing TBE vaccine uptake in children is essential to maximize the public health impact of TBE vaccination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004034","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T20:00:49Z","timestamp":1688587249000},"page":"927-931","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Effectiveness of Tick-borne Encephalitis Vaccines in Children, Latvia, 2018\u20132020"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4892-3763","authenticated-orcid":false,"given":"Dace","family":"Zavadska","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Clinical University Hospital, R\u012bga Stradin\u0161 University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3242-1630","authenticated-orcid":false,"given":"Zane","family":"Freimane","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Clinical University Hospital, R\u012bga Stradin\u0161 University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9586-2775","authenticated-orcid":false,"given":"Guntis","family":"Karelis","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurosurgery, Riga East University Hospital, R\u012bga Stradin\u0161 University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ineta","family":"Ermina","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Clinical University Hospital, R\u012bga Stradin\u0161 University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5866-7295","authenticated-orcid":false,"given":"Lisa R.","family":"Harper","sequence":"additional","affiliation":[{"name":"Medical Development and Scientific\/Clinical Affairs, Pfizer Vaccines, Pfizer Vaccines, Collegeville, Pennslyvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Bender","sequence":"additional","affiliation":[{"name":"Medical Development and Scientific\/Clinical Affairs, Pfizer Vaccines, Pfizer Vaccines, Collegeville, Pennslyvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Development and Scientific\/Clinical Affairs, Pfizer Vaccines, Pfizer Vaccines, Collegeville, Pennslyvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3120-7704","authenticated-orcid":false,"given":"Frederick J.","family":"Angulo","sequence":"additional","affiliation":[{"name":"Medical Development and Scientific\/Clinical Affairs, Pfizer Vaccines, Pfizer Vaccines, Collegeville, Pennslyvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Erber","sequence":"additional","affiliation":[{"name":"Medical Development and Scientific\/Clinical Affairs, Pfizer Vaccines, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antra","family":"Bormane","sequence":"additional","affiliation":[{"name":"Infectious Disease Surveillance and Immunization Unit, Centre for Disease Prevention and Control of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aija","family":"Griskevica","sequence":"additional","affiliation":[{"name":"Vaccine Medical Team, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-5630","authenticated-orcid":false,"given":"Jennifer C.","family":"Mo\u00efsi","sequence":"additional","affiliation":[{"name":"Medical Development and Scientific\/Clinical Affairs, Pfizer Vaccines, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1246-530X","authenticated-orcid":false,"given":"Luis","family":"Jodar","sequence":"additional","affiliation":[{"name":"Medical Development and Scientific\/Clinical Affairs, Pfizer Vaccines, Pfizer Vaccines, Collegeville, Pennslyvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis.","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ttbdis.2010.10.007","article-title":"Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia\u2014an overview.","volume":"2","author":"S\u00fcss","year":"2011","journal-title":"Ticks Tick Borne Dis"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"e0204844","DOI":"10.1371\/journal.pone.0204844","article-title":"Tick-borne encephalitis: a 43-year summary of epidemiological and clinical data from Latvia (1973 to 2016).","volume":"13","author":"Zavadska","year":"2018","journal-title":"PLoS One"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10354-012-0101-4","article-title":"Tick-borne encephalitis in children.","volume":"162","author":"Rostasy","year":"2012","journal-title":"Wien Med Wochenschr"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpn.2015.10.008","article-title":"MRI-imaging and clinical findings of eleven children with tick-borne encephalitis and review of the literature.","volume":"20","author":"von St\u00fclpnagel","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"R8-20250614","first-page":"484","article-title":"Severe forms of tick-borne encephalitis in children.","volume":"111","author":"Cizman","year":"1999","journal-title":"Wien Klin Wochenschr"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00006454-200307000-00009","article-title":"Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000.","volume":"22","author":"Lesnicar","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s150100050050","article-title":"Comparison of the epidemiological and clinical features of tick-borne encephalitis in children and adults.","volume":"28","author":"Logar","year":"2000","journal-title":"Infection"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpeds.2013.01.037","article-title":"Tick-borne encephalitis carries a high risk of incomplete recovery in children.","volume":"163","author":"Fowler","year":"2013","journal-title":"J Pediatr"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"104645","DOI":"10.1016\/j.idnow.2023.01.005","article-title":"Tick-borne encephalitis in pediatrics: an often overlooked diagnosis.","volume":"53","author":"Parfut","year":"2023","journal-title":"Infect Dis Now"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.01.004","article-title":"Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment.","volume":"62","author":"Riccardi","year":"2019","journal-title":"Eur J Intern Med"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jmv.2097","article-title":"Characterization of tick-borne encephalitis virus from Latvia: evidence for co-circulation of three distinct subtypes.","volume":"65","author":"Lundkvist","year":"2001","journal-title":"J Med Virol"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1016\/j.vaccine.2011.07.024","article-title":"Vaccines against tick-borne encephalitis: WHO position paper\u2014recommendations.","volume":"29","year":"2011","journal-title":"Vaccine"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0264-410X(92)90376-U","article-title":"Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes.","volume":"10","author":"Holzmann","year":"1992","journal-title":"Vaccine"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1016\/S0264-410X(01)00218-3","article-title":"Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains.","volume":"19","author":"Hayasaka","year":"2001","journal-title":"Vaccine"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4161\/hv.22766","article-title":"Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG).","volume":"9","author":"Zavadska","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 1","key":"R21-20250614","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience.","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/jiac075","article-title":"Tick-borne encephalitis in vaccinated patients: a retrospective case-control study and analysis of vaccination field effectiveness in Austria from 2000 to 2018.","volume":"227","author":"Santonja","year":"2023","journal-title":"J Infect Dis"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"11706","DOI":"10.1038\/s41598-022-15447-5","article-title":"Tick-borne encephalitis vaccine effectiveness and barriers to vaccination in Germany.","volume":"12","author":"Nygren","year":"2022","journal-title":"Sci Rep"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.vaccine.2021.12.028","article-title":"Effectiveness of TBE vaccination in southern Germany and Latvia.","volume":"40","author":"Erber","year":"2022","journal-title":"Vaccine"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"e061228","DOI":"10.1136\/bmjopen-2022-061228","article-title":"Retrospective, matched case-control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006-2020.","volume":"12","author":"Zens","year":"2022","journal-title":"BMJ Open"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s004150050077","article-title":"Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome.","volume":"244","author":"G\u00fcnther","year":"1997","journal-title":"J Neurol"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ttbdis.2018.02.007","article-title":"Self-reported tick-borne encephalitis (TBE) vaccination coverage in Europe: results from a cross-sectional study.","volume":"9","author":"Erber","year":"2018","journal-title":"Ticks Tick Borne Dis"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"102059","DOI":"10.1016\/j.ttbdis.2022.102059","article-title":"Vaccine uptake in 20 countries in Europe 2020: focus on tick-borne encephalitis (TBE).","volume":"14","author":"Pilz","year":"2023","journal-title":"Ticks Tick Borne Dis"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ije\/22.4.742","article-title":"Estimation of vaccine effectiveness using the screening method.","volume":"22","author":"Farrington","year":"1993","journal-title":"Int J Epidemiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:06:08Z","timestamp":1749945968000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004034","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,29]]}}}